Trust is key to getting providers on board when health systems look to roll out artificial intelligence, experts said at the HIMSS AI Leadership Strategy Summit in Chicago.
How to ensure healthcare workers benefit from AI Read More »
For the last two years, Keytruda has reigned as the world’s top-selling drug—a distinction under threat with key patent protections expiring in 2028.
As Exclusivity Loss Looms, Merck Wins Subcutaneous Approval for Keytruda Read More »
In an interview with German-language outlet Neue Zuercher Zeitung, Novartis CEO Vas Narasimhan said the company is exploring ways to remove or minimize the drug price gap between the U.S. and its other markets in similarly developed countries.
Novartis Looking for Constructive Ways To Bring Down Drug Costs in US Read More »
Heart surgeon Sudhir Srivastava saw a global need for less-invasive surgical care at an affordable price. His company, SS Innovations, built a robot that has now been used in more than 5,000 surgeries.
How SS Innovations is expanding robotic surgery’s reach Read More »
The acquisition of breakout obesity star Metsera should pump new life into Pfizer’s portfolio, which over the last two years has suffered from three discontinued assets.
Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition Read More »
Building and scaling biopharma workforces can go beyond recruiting permanent employees to include fractional workers and consultants. A Slone Partners executive discusses how these blended workforces operate, highlighting the strategic benefits.
Staying Agile: Blended Workforces Offer Strategic Approach to Business Needs Read More »
MapLight Therapeutics, the second biotech to launch a Nasdaq bid this month, is a neuro-focused company advancing treatments for Alzheimer’s disease psychosis and schizophrenia.
MapLight Keeps Biopharma’s IPO Flame Alight to Advance Alzheimer’s, Schizophrenia Drugs Read More »
El dron Dragonfly, que, si no surgen retrasos, partirá de la Tierra en 2028 a bordo de una nave que lo llevará a Titán, una luna de Saturno, está ya en una fase bastante avanzada de construcción. Dragonfly, un helicóptero robótico del tama&nt …
Avanza la construcción del dron nuclear que volará por Titán Read More »
Un estudio realizado por un equipo internacional ha validado la eficacia de un fármaco en adultos que padecen la neurofibromatosis tipo 1. El estudio, cuya primera firmante es la doctora Alice Chen, del Instituto Nacional del Cáncer en Bethesda, Maryland, Estados Unidos, ha de …
Nuevo fármaco contra la neurofibromatosis tipo 1 Read More »
Un estudio reciente ha demostrado cómo los modelos de inteligencia artificial pueden detectar rasgos de la personalidad a partir de textos escritos y, por primera vez, ha logrado analizar detalladamente cómo estos sistemas toman decisiones al respecto. Estos resultados abren nuevas v&i …
